로딩 중…
StockDiggingStockDigging

Cytek Biosciences, Inc.

CTKB· NASDAQ
$5.30+1.73%
2026-09-18

Financials

Valuation Metrics

Cytek Biosciences, Inc.'s Market Cap is $684M. At end of 2025 it was $647M. Ranked #2669 of 3,121 in US market (top 86%), #1142 of 1,463 on NASDAQ (top 78%), #164 of 205 in Health Care Equipment & Services (top 80%) by Market Cap.

Investment Metrics(as of 2026-09-18)

MetricValue
Size
Market Cap$684M
Revenue$207M
Net Income$-81M
Total Assets$447M
Net Assets$322M
Employees702
Value
P/B2.13x
P/S3.31x
FCF Yield-1.76%
Profitability
ROE-25.03%
ROA-18.03%
Op. Margin-21.60%
Revenue Growth5.44%
Financial Health
Debt Ratio38.82%
Total Debt$26M
FCF$-12M
Cash$74M
Current Ratio4.48x
Dividend
Div. Yield0.00%
Payout Ratio0.00%
Performance
1Y Return29.58%
1M Return12.77%
From 52W High-14.24%
1Y MDD-42.86%
Trading
Volume1,751,423 shares
Trading Value$9M
Per Share
EPS$-0.62
BPS$2.49

Company Info

CEO Dr. Wenbin Jiang Ph.D.
Employees 702
HQ Fremont, United States

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.